BioSpectrum Asia

The National University Hospital (NUH) and the National University of Singapore (NUS) Clinical Imaging Research Centre (CIRC) have jointly launched the Molecular Imaging and Theranostic Centre, a novel integrated clinical, education, research & development facility that brings together advanced diagnostics, targeted therapy and pioneering research. #Molecular #Imaging #Theranostic #Centrenadvanced #diagnostics #therapy #research #clinical #education #development https://lnkd.in/dRm7phgk

The countdown is on for Revive ME, the region’s first dedicated longevity and health innovation platform! We’re honored to host a lineup of world-class speakers and visionary companies who are shaping the future of HealthSpan, regenerative science, and digital health across the Middle East and beyond. From global biotech pioneers to leaders in longevity innovation, this is where science meets investment, and innovation goes from lab to market. Don't Miss Out! Get your Delegate Pass Now  https://lnkd.in/dsAHt6Zu Revive ME Maria AlQassim UAE Ministry of Economy & Tourism, Dr. Asma Al Mannaei  Department of Health Abu Dhabi , Dr.Ramadan Alblooshi Dubai Health Authority, Lucie Berger—European Union Ambassador to the United Arab Emirates Dimitris Moulavasilis — M42 Health Richard Marshall CBE Juvenescence® Alex Aliper — Insilico Medicine Elena Bonfiglioli — Microsoft Dr. Kingsley Owosela — TAQA Group Mohamed Nasser — Amgen Yasir Khan MD, MBA Oracle Health LLC Bartlomiej Piechowski-Jozwiak — Institute for Healthier Living Abu Dhabi Fawad Khan Cleveland Clinic Abu Dhabi Daniel Wallerstorfer— Novogenia GmbH Rahat Ghazanfar Sheikh Shakhbout Medical City - SSMC #ReviveME #LongevityScience #DigitalHealth #HealthcareInnovation #RegenerativeMedicine #MiddleEastInnovation #Healthspan #WellnessLeadership

A team of researchers from NUS Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and China's Tsinghua University has unveiled a new messenger ribonucleic acid (mRNA) vaccine technology that could make future vaccines safer, more effective, and less burdensome for patients. #patients #effective #future #vaccines #ribonucleicacid #medicine #university #viral #infection #protection https://lnkd.in/deNhdS8A

A world leader in artificial intelligence-enabled medical technologies is expanding its global footprint in Victoria, turbocharging the state’s position as a hub for lifesaving medical research, health technologies and AI. Minister for Economic Growth and Jobs Danny Pearson announced that Optain Health will establish its Asia-Pacific headquarters and substantially expand its global Research and Development (R&D) and Engineering Hub in Melbourne. #artificialintelligence #medicaltechnologies #research #headquarters #Research #Development #lifesaving #medtech https://lnkd.in/dqrknqsC

“AI holds enormous promise to aid clinicians in making informed decisions among many different treatment pathways” In July 2025, the FDA approved the Oncomine Dx Express Test, a next-generation sequencing (NGS) platform developed by Thermo Fisher Scientific. The firm is now seeking approval in Japan, where cancer is the leading cause of death, with over one million new cases diagnosed annually. Jane Li, Senior Director of Pharma CDx and CRO Partnerships, Clinical Sequencing, discusses how the new system advances on the earlier test, trends in pharma–diagnostic collaborations globally and in Asia, key challenges in scaling NGS adoption, and the role of automation and AI in shaping the future of personalised medicine. https://lnkd.in/drnDFev2 Jane Li #PrecisionOncology, #CompanionDiagnostics, #NextGenSequencing #CancerCareInnovation, #PharmaTech #AsiaHealthcare, #HealthcareEquity

The UK BioIndustry Association (BIA) and Japan Bioindustry Association (JBA) have signed a Memorandum of Understanding (MoU), agreeing to work together to connect the two countries’ life sciences and biotech ecosystems to accelerate medical innovation and the commercialisation of engineering biology. #commercialisation #engineering #biology #medical #innovation #connect #lifesciences #bioindustry https://lnkd.in/d9mNUAy2

Israel-based prospecbio, an evolving biotech company dedicated to providing highly purified proteins to the global research community, has announced the launch of its latest product: CHO cell–derived recombinant Activin-A, now available for immediate delivery worldwide. #biotech #company #globalresearch #latest #product #purified #proteins #research #community #immediate #delivery https://lnkd.in/dT8seguh

Roche has announced its strategic collaboration with the Office for Attracting Strategic Enterprises (OASES) to accelerate healthcare innovation and strengthen Hong Kong's role as a leading hub for life sciences and medical technology in the Asia Pacific region. #strategic #collaboration #strategic #accelerate #healthcare #innovation #leading #hub #lifesciences #medicaltechnology https://lnkd.in/da4jzcDp

Singapore's NUS Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), has launched a new Clinical Trial Centre under its NUS Academy for Healthy Longevity, a pioneering hub to advance clinical research and catalyse educational excellence in precision geromedicine. #educational #excellence #geromedicine #medicines #University #Clinical #Trial #Centre #research #catalyse https://lnkd.in/d4msquHt

Mirxes, a leading and only publicly-listed molecular cancer early detection company in Asia Pacific, has been granted regulatory approval for its flagship product, GASTROClear™, by China’s National Medical Products Administration (NMPA).  #molecular #cancer #earlydetection #regulatory #approval #Medical #Products #Administration #flagship https://lnkd.in/dcSMQ9jA